Dan Loeb Is Still Bullish On Amgen, Allergan and Dow Chemical
August 18, 2015 at 16:33 PM EDT
Over the second quarter of the year, Dan Loeb’s Third Point started 16 new positions, sold out of nine, trimmed its exposure to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.